2015 Speakers

Next Generation Dx Summit 2015 – Speaker List 

Gyorgy Abel, M.D., Ph.D., Director, Molecular Diagnostics, Immunology & Clinical Chemistry, Laboratory Medicine, Lahey Hospital & Medical Center

Alex J. Adams, Pharm.D., IOM, Vice President, Pharmacy Programs, National Association of Chain Drug Stores (NACDS)

Nishant Agrawal, M.D., Associate Professor, Otolaryngology-Head and Neck Surgery, Johns Hopkins University School of Medicine

Robert Albert Anders, M.D., Ph.D., Associate Professor, Pathology, Johns Hopkins School of Medicine

Todd E. Arnold, Ph.D., Managing Director, Mount Sinai Genetic Testing Laboratory; Genetics and Genomic Sciences, Icahn Institute for Genomics and Multiscale Biology

Naomi Aronson, Ph.D., Executive Director, Technology Evaluation Center (TEC), Blue Cross Blue Shield Association

Reiner Babiel, Ph.D., Executive Director, Consulting, RBDC

Pinar Bayrak-Toydemir, M.D., Ph.D., Medical Director, Molecular Genetics and Genomics Laboratory, ARUP; Associate Professor, Pathology, University of Utah School of Medicine

Holger Becker, Ph.D., Founder & CSO, microfluidic ChipShop GmbHx

Melissa K. Bennett, MS, CGC, Clinical Director, Laboratory Management Program, CareCore National

Elise Berliner, Ph.D., Director, The Technology Assessment Program, AHRQ

ChetanBettegowda, M.D., Ph.D., Assistant Professor, Neurosurgery and Oncology, Johns Hopkins University School of Medicine

Rebecca Blanchard, Ph.D., Executive Director, Genetics and Pharmacogenomics, Head, of Clinical Pharmacogenomics, Merck & Co., Inc.

Ihor Boszko, Vice President, Business Development, Xagenic Inc.

Jeff Boyd, Ph.D., Senior Vice President, Molecular Medicine; The Robert C. Young, MD Chair in Cancer Research; Executive Director, Cancer Genome Institute; Chief, Division of Molecular Pathology; Professor, Cancer Biology Program, Fox Chase Cancer Center

Ivan Brukner, Ph.D., Molecular Diagnostics Lab Director, Medical Diagnostics, Jewish General Hospital

Andreas Caduff, Ph.D., CEO, Biovotion AG

BarbaraCammarata, Counsel, Sidley Austin LLP

Grant R. Campany, Senior Director & Prize Lead, Qualcomm Tricorder XPRIZE & Nokia Sensing XCHALLENGE

Peggy Carter, Ph.D., Global Head, Drug Regulatory Affairs, Novartis Companion Diagnostics

C. Thomas Caskey, M.D., FACP, FACMG, FRSC, Professor, Molecular & Human Genetics, Baylor College of Medicine

Lon Castle, M.D., CMO, Molecular Genetics and Personalized Medicine, CareCore National

Eugene Chan, M.D., Founder, CEO, DNA Medicine Institute

John Chiang, Ph.D., FACMG, Director, Casey Molecular Diagnostics Laboratory, Oregon Health and Science University

Joseph Chin, Senior Medical Advisor & Acting Deputy Director, US Dept of Health & Human Services

Charles Chiu, M.D., Ph.D., Associate Professor, Lab Medicine and Infectious Diseases; Director, UCSF-Abbott Viral Diagnostics and Discovery Center; Associate Director, UCSF Clinical Microbiology Laboratory

Danielle Chun, MPH, Genomics Informaticist, VINCI Services, VA

Melina Cimler, Ph.D., Senior Vice President, Quality & Regulatory, Adaptive Biotechnologies

John Clarkson, Ph.D., CEO, Atlas Genetics Ltd.

Terah B. Collins, Genomics Strategist, Cerner Corporation

Peter Collins, Chief Commercial Officer, Premaitha Health

Robert D. Daber, Ph.D., Director, Research and Development and Sequencing Operations, Bio-Reference Laboratories

Edward R. Damiano, Ph.D., Professor, Biomedical Engineering, Boston University

Biswajit Das, Ph.D., Senior Scientist, MoCha, Frederick National Laboratory for Cancer Research Leidos Biomedical Research, Inc., National Cancer Institute (NCI)

Stephen P. Day, Ph.D., IVD Consultant (Member, AMP Professional Relations Committee)

Iwijn DeVlaminck, Ph.D., Assistant Professor, Biomedical Engineering, Cornell University

Allison M. Dering-Anderson, BA, Pharm.D., RP, FAAIM, Clinical Assistant Professor, Pharmacy, University of Nebraska College of Pharmacy

Luis A. Diaz, M.D., Associate Professor, Oncology, Johns Hopkins Sidney Kimmel Comprehensive Cancer Center

Maximilian Diehn, M.D., Ph.D., Assistant Professor, Radiation Oncology, Stanford Cancer Institute, Institute for Stem Cell Biology & Regenerative Medicine, Stanford University

JenniferDien Bard, Ph.D., D(ABMM), FCCM, Assistant Professor, Clinical Pathology, Keck School of Medicine, University of Southern California; Director, Clinical Microbiology Laboratory; Acting Director, Clinical Virology Laboratory, Pathology and Laboratory Medicine, Children’s Hospital Los Angeles

Marisa Dolled-Filhart, Ph.D., Director, Pathology and Companion Diagnostics, Molecular Biomarkers and Diagnostics, Clinical Flow Cytometry and Molecular Pathology, Merck & Co., Inc.

Sherry Dunbar, Ph.D., Director, Scientific Affairs, Luminex Corporation

Eran Eden, CEO, MeMed

Kenneth Emancipator, M.D., Executive Medical Director, Molecular Biomarkers and Diagnostics, Merck Research Laboratories

Alan L. Epstein, M.D., Ph.D., Professor, Pathology, University of Southern California, Keck School of Medicine

Mark Erlander, Ph.D., CSO, Trovagene

Helen Fernandes, Ph.D., Director, Molecular Pathology, Pathology & Laboratory Medicine, Weill Cornell Medical College    

Kyle Fetter, Vice President, Advanced Diagnostics, XIFIN, Inc.

Thomas M. File, Jr., M.D., MSc, MACP, FIDSA, FCCP, Chair, Division of Infectious Disease, Summa Health System; Professor, Internal Medicine, Master Teacher, Chair, Infectious Disease Section, Northeast Ohio Medical University

Louis Fiore, M.D., Executive Director, MAVERIC, Boston VA Healthcare System

Andrew C. Fish, Executive Director, AdvaMedDx

Mustapha S. Fofana, Ph.D., Associate Professor, Mechanical, Biomedical and Manufacturing Engineering, Worcester Polytechnic Institute

John Fox, M.D., Associate Vice President, Medical Affairs, Priority Health

Gus Frangou, Ph.D., Director, Clinical Diagnostics, Cellecta Inc.

Felix W. Frueh, Ph.D., CSO, Human Longevity, Inc.

Carolina Garcia-Rizo, Ph.D., MBA, Director, Business Development, Roche Molecular Systems

Giulio Genovese, Ph.D., Computational Biologist, Stanley Center for Psychiatric Research, Broad Institute

Harry Glorikian, Healthcare Consultant

David R. Goodlett, Ph.D., Issac E. Emerson Professor, Pharmaceutical Sciences, School of Pharmacy; Mass Spectrometry Facility Director, University of Maryland

Erynn Gordon, MS, LCGC, Medical Marketing Director, 23andme

Brian Gorin, Managing Principal, Analysis Group

George A. Green IV, Ph.D., Group Director, Pharmacodiagnostic Center of Excellence, Bristol-Myers Squibb

Wayne W. Grody, M.D., Ph.D., UCLA School of Medicine

Yimin Guan, Ph.D, Microfluidic Business Development, Funai TSG Group

Gary Gustavsen, Vice President, Health Advances LLC

Karen Gutekunst, Ph.D., Vice President, IVD Development, Oncology, Illumina

Steven Gutman, M.D., Myraqa Strategic Advisor, Illumina, Inc.

Sam M. Hanash, M.D., Ph.D., Professor, Molecular Pathology, Division of Pathology/Lab Medicine, The University of Texas MD Anderson Cancer Center

John W. Hanna, MBA, Vice President, Endocrinology, Veracyte, Inc.

Erol Harvey, CEO, miniFAB

Matthew J. Hawryluk, Ph.D., Senior Director, Corporate & Business Development, Foundation Medicine, Inc.

Joe Don Heath, Ph.D., Vice President, Market Development Diagnostics, NuGEN

Priti Hegde, Ph.D., Anti-Angiogenesis and Cancer Immunotherapy Franchises Biomarker Lead, Oncology Biomarkers, Genentech

Michael J. Heller, Ph.D., Professor, Nanoengineering & Bioengineering, University of California San Diego

Fred R. Hirsch, M.D., Ph.D., Professor, Medicine and Pathology, University of Colorado Cancer Center; CEO, International Association for the Study of Lung Cancer (IASLC)

Kenneth C. Hohmeier, Pharm.D., Assistant Professor, Clinical Pharmacy; Director, Community Affairs, College of Pharmacy, University of Tennessee

Jocelyn A. Holash, Ph.D., Vice President, Translational Sciences, BioClin Therapeutics, Inc.

David S. B. Hoon, MSc, Ph.D., Chief of Scientific Intelligence, Director, Molecular Oncology, Director, JWCI Sequencing Center, John Wayne Cancer Institute

Shuguang Huang, Ph.D., Associate Vice President, Biostatistics, Helomics

Nina Hunter, Ph.D., Regulatory Scientist, Division of Molecular Genetics and Pathology, Food and Drug Administration (FDA)

David Issadore, Ph.D., Assistant Professor, Bioengineering and Electrical Engineering, University of Pennsylvania

Scott A. Jackson, BSPh, RPh, Sr. Group Manager, Managed Care, Operations, Target Corporation

David James, Senior Vice President, Diagnostics, Invetech

François Jean, Ph.D., Scientific Director, UBC Facility for Infectious Disease and Epidemic Research (FINDER), Associate Professor, Microbiology and Immunology, University of British Columbia

Stephen Johnston, Ph.D., Co-Director, The Biodesign Institute, Innovations in Medicine, Professor, College of Liberal Arts and Sciences, School of Life Sciences, Arizona State University

Donald Jones, CEO, Trial Fusion, Inc.

Scott M. Kahn, Ph.D., CSO, Oncostem Biotherapeutics, LLC.; Adjunct Associate Research Scientist, Urology, Columbia University; Chairman, Biomarkers Council, International Cancer Advocacy Network

Shana Kelley, Ph.D., CTO, Xagenic Inc.

Daniel R. Kerls, MBA, OTR/L, Director, Ambulatory Operations, CVS MinuteClinic

Julie Khani, Senior Vice President, American Clinical Laboratory Association

Kiran K. Khush, M.D., MAS, Assistant Professor, Medicine, Cardiovascular Medicine, Stanford University

Christopher R. Kinsinger, Ph.D., Program Manager, Office of Cancer Clinical Proteomics Research, NCI

Roger Klein, M.D., J.D., Molecular Oncology, Medical Director, Cleveland Clinic Foundation

Ira Klein, M.D., Medical Director, Aetna

Donald G. Klepser, Ph.D., MBA, Associate Professor, Pharmacy Practice, University of Nebraska Medical Center

Michael E. Klepser, Pharm.D., FCCP, Professor, Pharmacy Practice, Ferris State University College of Pharmacy

Lilly Kong, Senior Director, Assay Development, Assay Development, Qiagen

Casey Kozlowski, Director, Diagnostic Testing, Walgreens

Scott Kulich, M.D., Ph.D., Associate Professor, Pathology, Division of Pathology and Division of Neuropathology, VA Pittsburgh Healthcare System (VAPHS)

Marc Ladanyi, M.D., Chair, Molecular Oncology, Memorial Sloan-Kettering Cancer Center

Wilbur A. Lam, M.D., Ph.D., Assistant Professor, Pediatrics and Biomedical Engineering, Emory University and Georgia Institute of Technology

Raymond J. Langley, Ph.D., Associate Research Scientist, Lovelace Respiratory Research Institute

Jordan S. Laser, M.D., Medical Director, Pathology and Laboratory Medicine, North Shore Long Island Jewish Health System (Member, AMP Professional Relations Committee)

Andrea H. Lauber, Ph.D., Executive Director, Business Development, Clinical Biomarkers and Pharmacodiagnostics, Bristol-Myers Squibb

James V. Lawler, M.D., MPH CDR MC USN, ACESO Director, NMRC - Frederick

James F. Leary, Ph.D., Professor, Basic Medical Sciences & Biomedical Engineering,

Purdue University

Matthew Lebo, Ph.D., FACMG, Director, Bioinformatics; Assistant Laboratory Director, Personalized Medicine Laboratory for Molecular Medicine, Partners Healthcare; Instructor, Pathology, Brigham and Women’s

Hospital, Harvard Medical School

Nathan A. Ledeboer, Ph.D., D(ABMM), Assistant Professor, Medical Director, Clinical Microbiology, Medical College of Wisconsin

Eunice Lee, Ph.D., Regulatory Scientist, OIR, FDA CDRH

Jerry Lee, CEO, True Diagnostics, Inc.

Paul Lem, CEO and Founder, Spartan Bioscience Inc.

Han Liang, Ph.D., Associate Professor and Deputy Chair, Bioinformatics and Computational Biology, R. Lee Clark Fellow, The University of Texas MD Anderson Cancer Center

Jason Lih, Ph.D., Principal Scientist, Molecular Characterization Group, Leidos Biomedical Research, Inc./Frederick National Laboratory for Cancer Research

Jimmy Lin, M.D., Ph.D., MHS, Director, Clinical Genomics, Genetics Branch, Center for Cancer Research, National Cancer Institute (NCI), National Institutes of Health (NIH)

Catherine Lofton-Day, Ph.D., Principal Scientist, Amgen

Shaun Lonergan, Ph.D., Vice President, Precision Medicine, Metabolon

Matthew C. Lorence, Ph.D., Executive Vice President, Marketing and Sales, Edge Biosystems, Inc.

Arthur Lurvey M.D., Contractor Medical Director, JE Noridian Healthcare Solutions

Julie Lynch, Ph.D., MBA, RN, Principal Investigator, Veterans Health Administration

ElaineLyon, Ph.D., Medical Director, Molecular Genetics, ARUP (AMP 2014 President and Member, AMP Professional Relations Committee)

Elizabeth A. Mansfield, Ph.D., Director, Personalized Medicine, FDA CDRH

Rong Mao, M.D., FACMG, Associate Professor, Pathology, University of Utah School of Medicine; Medical Director, Molecular Genetics and Genomics, ARUP Laboratories

Adam Marsh, Ph.D., Associate Professor, Bioinformatics and Computational Biology, University of Delaware

John Martignetti, M.D., Ph.D., Genetics and Genomic Sciences, Pediatrics, Obstetrics/Gynecology & Reproductive Sciences and Oncological Sciences, Icahn School of Medicine at Mount Sinai

Anne-Marie Martin, Ph.D., Head, Molecular Medicine and Precision Medicine & Diagnostics, GlaxoSmithKline

Ron Mazumder, Ph.D., MBA, Global Head, R&D and Operations, Janssen Diagnostics, Janssen Pharmaceutical Companies of Johnson & Johnson

Joan S. McClure, Senior Vice President for Clinical Information and Publications, NCCN

Anna McCollister-Slipp, Co-Founder, Galileo Analytics

Jamie McDonald, MS, Licensed Genetic Counselor, Co-Director, HHT Center of Excellence; Assistant Professor, Department of Pathology, University of Utah

J. Joseph Melenhorst, Ph.D., Director, Product Development & Correlative Sciences Labs, Translational Research Program, Pathology and Laboratory Medicine; Adjunct Associate Professor, Abramson Family Cancer Research Institute, Perelman School of Medicine, University of Pennsylvania

Jason Merker, M.D., Ph.D., Co-Director, Stanford Clinical Genomics Service;  Assistant Professor, Pathology, Stanford University School of Medicine

Chris Moriarty, Global Manager, Pharma Services, Randox Biosciences

Carl Morrison, M.D., DVM, Executive Director, Center for Personalized Medicine; Director, Roswell Park Cancer Institute

Jennifer Morrissette, Ph.D., Scientific Director, Clinical Cytogenetics Laboratory, Clinical Director, Center for Personalized Diagnostics (CPD), University of Pennsylvania Perelman School of Medicine

Shashi K. Murthy, Ph.D., Associate Professor, Chemical Engineering, Northeastern University

Jerod Nagel, Pharm.D., BCPS (AQID), Clinical Specialist, Infectious Diseases, Clinical Assistant Professor, Director Infectious Diseases Residency, University of Michigan Hospital and Health Systems, University of Michigan, College of Pharmacy

Mark E. Nunes, M.D., Associate Professor, Pediatrics, Division Chief, Medical Genetics, Kaiser Permanente

Randall J. Olsen, M.D., Ph.D., Associate Member, Center for Molecular and Translational Human Infectious Diseases Research, Houston Methodist Research Institute

Jonathan Pan, Ph.D., Head, Oncology Companion Diagnostic and Disease Strategy, Novartis Pharmaceuticals Corporation

Klaus Pantel, M.D., Professor and Founding Director, Institute of Tumor Biology, University Medical Center Hamburg-Eppendorf

Nickolas E. Papadopoulos, Ph.D., Professor, Oncology Cancer Biology, Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University

Ben H. Park, M.D., Ph.D., Associate Professor, Oncology, Johns Hopkins University

Sonya Parpart-Li, Ph.D., Associate Scientist, Personal Genome Diagnostics

Elissa Passiment, Executive Vice President, American Society for Clinical Laboratory Science (ASCLS)

Brad Patay, M.D., CMO, Genection

Kadamb Patel, Ph.D., Program Manager, Biosensor, Research Scientist, Centre of Molecular Diagnostics, School of Applied Science, Temasek Polytechnic

Jean B. Patel, Ph.D., D(ABMM), Deputy Director, Office of Antimicrobial Resistance, Division of Healthcare Quality Promotion, CDC

Yarmela Pavlovic, Partner, Hogan Lovells US LLP

Valentina I. Petkov, M.D., MPH, Health Scientist/Program Officer, Surveillance Research Pro-gram, Division of Cancer Control and Population Sciences National Cancer Institute

Jean-Yves Pierga, M.D., Ph.D., Circulating Cancer Biomarkers Lab, SiRIC, Translational Research and Medical Oncology, Institut Curie and University Paris Descartes

William Pignato, Founder and Principal, W.J. Pignato & Associates, LLC

German Pihan, M.D., Staff Pathologist & Director, Hematopathology Lab, Pathology, Beth Israel Deaconess Medical Center

Jamie L. Platt, Ph.D., Vice President, Genomic Solutions, Geneuity

DonnaPolizio, Senior Director, Managed Care & Reimbursement, Genomic Health

Martin P. Powers, M.D., Molecular Genetic Pathologist, Co-Lab Director; NYS Lab Director, InVitae

Corrado Priami, Ph.D., President & CEO, The Microsoft Research and University of Trento Centre for Computational and Systems Biology

Daryl Pritchard, Ph.D., Vice President, Science Policy, Personalized Medicine Coalition

Girish Putcha, M.D., Ph.D., Director, Laboratory Science, Palmetto GBA (MolDX)

Bruce Quinn, M.D., Ph.D., Senior Health Policy Specialist, Foley Hoag LLP

Paul W. Radensky, M.D., Partner, Health Products Regulation Group, McDermott Will & Emery LLP

Mitch Raponi, Ph.D., Senior Director, Molecular Diagnostics, Clovis Oncology

Katherine Richardson, Ph.D., Vice President, Research & Development, Transgenomic, Inc.

John Ridge, Senior Director Managed Care & Reimbursement, EXACT Sciences Corp

David L. Rimm, M.D., Ph.D., Yale University

James C. Ritchie, Ph.D., Medical Director & Professor, Pathology & Laboratory Medicine, Emory University

Scott Rodig, M.D., Ph.D., Pathology, Brigham & Women’s Hospital and Dana-Farber Cancer Institute, Associate Professor, Pathology, Harvard Medical School

Nitzan Rosenfeld, Ph.D., Senior Group Leader, CRUK-CI, University of Cambridge; CSO, Inivata, Ltd.

Charles Saginario, Ph.D., Scientist, CRS Labs, Janssen Diagnostics

Avni B. Santani, Ph.D., Assistant Professor, Clinical Pathology, University of Pennsylvania School of Medicine; Scientific Director, Molecular Genetics Laboratory, The Children’s Hospital of Philadelphia

Sriram Sathy, Ph.D., Director, Target and Biomarker Discovery, Jounce Therapeutics

Alexander Sbordone, J.D., Operations Manager, MinuteClinic, CVS Caremark Corporation

Richard L. Schilsky, M.D., FACP, FASCO, CMO, American Society of Clinical Oncology

Therese Seldon, Vice President, Operations, Immunexpress

Hemanth Shenoi, Ph.D., Director, Business Development, Lucigen

Heike Sichtig, Ph.D., Medical Countermeasures / Multiplex, Microbiology Devices, Center for Devices (CDRH), FDA

Kate Simon, Ph.D., Senior Consultant, Biologics Consulting Group, Inc.

Giulia Siravegna, MSc, Ph.D. Student, Molecular Medicine, Oncology, School of Medicine, University of Torino; IRCCS-Candiolo Cancer Institute

David I. Smith, Ph.D., Professor, Laboratory Medicine & Pathology, Mayo Clinic

Evan Snitkin, Ph.D., Assistant Professor, Microbiology and Immunology, Medicine, Division of Infectious Diseases, University of Michigan Medical School

Michael R. Speicher, M.D., Department Chair, Institute of Human Genetics, Medical University of Graz

Sandra Statz, Vice President, Clinical, Quality & Regulatory, Exact Sciences

Ester Stein, Director, Corporate Reimbursement, Abbott Molecular

Michael Super, Ph.D., Senior Staff Scientist, Advanced Technology Team, Wyss Institute, Harvard University

Pamela Swatkowski, Director, Global Regulatory Affairs, Abbott Molecular

Janis Taube, M.D., MSc, Director, Dermatopathology; Assistant Professor, Dermatology and Pathology, Johns Hopkins

Clive R. Taylor, M.D., Ph.D., Professor, Chairman of the Department of Pathology, USC Keck School of Medicine, Los Angeles

Živana Težak, Ph.D., Associate Director, Science and Technology, Personalized Medicine, Office of In Vitro Diagnostic Device Evaluation and Safety (OIVD), Center for Devices and Radiological Health (CDRH), FDA

Alain R. Thierry, Ph.D., Senior Investigator, Research Institute in Oncology of Montpellier, INSERM

Ali Tinazli, Ph. D., Vice President, Head, Business Development & Sales, Sony DADC Biosciences

Ephraim L. Tsalik, M.D., MHS, Ph.D., Assistant Professor, Medicine, Division of Infectious Diseases, Center for Applied Genomics & Precision Medicine, Medicine, Duke University School of Medicine

Gregory J. Tsongalis, Ph.D., Director, Molecular Pathology; Professor, Pathology, Geisel School of Medicine, Dartmouth University

Paul Tumeh, Ph.D., CSO, Dermatology, Acteris, Inc.

Abraham Tzou, M.D., Medical Officer, Center for Devices and Radiological Health, Food and Drug Adminstration

Bastiaan Van Der Baan, Vice President, Clinical Affairs, Agendia

Eric vanGieson, Ph.D., Director, R&D, Diagnostics and Biosurveillance, MRIGlobal

Victor E. Velculescu, M.D., Ph.D., Professor, Oncology; Co-Director, Cancer Biology, Johns Hopkins Kimmel Cancer Center

Erik Viirre, M.D., Ph.D., Adjunct Professor, Neuroscience, University of California, San Diego; Surgery and Cognitive Science, Arthur C. Clarke Center and XPRIZE Foundation

John F. Warren, Senior Director, McDermott+Consulting LLC

Krystalyn K. Weaver, Pharm.D., RPh, Director, Policy and State Relations, National Alliance of State Pharmacy Associations

Karen Weck, M.D., Professor of Pathology & Laboratory Medicine and Genetics, University of North Carolina, Chapel Hill

Anton Wellstein, M.D., Ph.D., Professor, Oncology, Georgetown University

Christian Whitchurch, Manager, Detection, Diagnostics & Biosurveillance, Defense Threat Reduction Agency (DTRA)

Mark Wilks, Ph.D., Lead Clinical Scientist, Microbiology, Barts Health NHS Trust

P. Mickey Williams, Ph.D., Director, Molecular Characterization & Clinical Assay Development Laboratory (MoCha), Frederick National Laboratory for Cancer Research

Henrik Winther, VICE PRESIDENT, Corporate Business Development, Dako, an Agilent Technologies Company

Rina Wolf, Vice President, Strategic Commercialization, Consulting & Industry Affairs, XIFIN, Inc.

Lawrence J. Worden, Vice President and Senior Partner, Market Diagnostics International

Baolin Zhang, Ph.D., Senior Investigator, Office of Biotechnology Products, Center for Drug Evaluation and Research, Food and Drug Administration

Noam Ziv, Founder & CEO, Kesembe, Inc.

Justin Zook, Ph.D., Researcher, National Institute of Standards and Technology (NIST)